Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

Bitcoin Miners Dominate the List. Summit Therapeutics Inc. (NASDAQ:SMMT) is one of Wednesday’s top performers. Summit ...

Summit Therapeutics Inc. (NASDAQ:SMMT) is one of the 10 Stocks Going Wild. Summit Therapeutics jumped by 7.61 percent on ...

Summit Therapeutics' HARMONi trial data for ivonescimab showed a clinical benefit but narrowly missed statistical ...

Biotech company CRISPR Therapeutics has a market cap of around $5 billion, but it has the potential to be much more valuable ...

Summit Therapeutics (NASDAQ: SMMT) has risen in prominence in the past two years thanks to a promising pipeline candidate, ivonescimab, a potential cancer treatment. It doesn't have a single drug ...

Alongside her husband, Bob Duggan, Maky Zanganeh has guided cancer drug developer Summit Therapeutics to reach staggering new ...

Shares of biotech Summit Therapeutics (NASDAQ: SMMT) skyrocketed 583.7% in 2024, according to data from S&P Global Market Intelligence. Summit was an early-stage biotechnology stock heading into ...

Summit Therapeutics CEO Robert "Bob" Duggan. Photograph by Christian Peacock/The Forbes Collection. The American Society of Clinical Oncology held its annual conference in Chicago this past week, ...